Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$583.91M
↑ 44% above average
Average (9y)
$405.60M
Historical baseline
Range
High:$583.91M
Low:$136.00M
CAGR
+17.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $583.91M | +11.5% |
| 2023 | $523.74M | -9.7% |
| 2022 | $580.02M | +14.9% |
| 2021 | $504.71M | +7.9% |
| 2020 | $467.94M | +24.4% |
| 2019 | $376.10M | -4.4% |
| 2018 | $393.54M | +37.1% |
| 2017 | $287.02M | +41.4% |
| 2016 | $203.02M | +49.3% |
| 2015 | $136.00M | - |